Analysts think OLMA stock price could increase by 179%
Nov 13, 2025, 12:26 PM
5.52%
What does OLMA do
Olema Pharmaceuticals, based in San Francisco, develops targeted therapies for women's cancers, notably its lead candidate OP-1250, currently in Phase I/II trials for metastatic ER-positive breast cancer. The company went public on November 19, 2020, and employs 75 staff.
10 analysts think OLMA stock price will increase by 178.58%. The current median analyst target is $22.44 compared to a current stock price of $8.05. The lowest analysts target is $18.18 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.